F.A.S.T.-BE FAST Stroke Warning Signs Study
NCT06483165 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2024-07-03
Summary
The goal of this randomized controlled trial is to learn whether the BE FAST (Balance, Eyes, Face, Arm, Speech, and Time) acronym works at least as well or better than the F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911) acronym in helping participants learn and remember the warning signs of a stroke. The main questions it aims to answer are:
* Does the BE FAST acronym increase understanding among participants that calling 911 is the right first step they should take if a stroke is suspected?
* Does the BE FAST acronym perform as well as or better than the F.A.S.T. acronym in helping participants remember stroke warning signs on a letter-aided open-ended basis? Researchers will compare the BE FAST acronym to the F.A.S.T. acronym to see if the BE FAST acronym works at least as well as the F.A.S.T. acronym in teaching participants about the warning signs of a stroke and the importance of calling 911 if they suspect a stroke.
Participants will:
* Take a survey about their knowledge of stroke and its symptoms
* Watch a short video about one of the acronyms and then answer more questions about what they learned
* Take another survey after 30 days about the acronym they learned about
Conditions
- Stroke, Acute
Interventions
- OTHER
-
BE FAST Educational video
A 1-minute educational video format using BE FAST. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
- OTHER
-
F.A.S.T. Educational Video
A 1-minute educational video format using F.A.S.T. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Opeolu Adeoye, MD · Washington University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-03-28
- Primary Completion
- 2024-07-31
- Completion
- 2024-07-31
Countries
- United States
Study Locations
More Related Trials
-
The Stroke Warning Information and Faster Treatment Study (SWIFT)
NCT00415389 ·Status: TERMINATED ·Phase: PHASE2
-
Stroke Education Intervention Trial - Pilot
NCT01115660 ·Status: COMPLETED ·Phase: NA
-
Ultrasound for Acute Field Triage of Stroke
NCT05845203 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.
NCT06472921 ·Status: COMPLETED ·Phase: PHASE2
-
Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
NCT07073469 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
NCT02484027 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients
NCT04652128 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
NCT07324837 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke
NCT02813512 ·Status: COMPLETED ·Phase: PHASE1
-
Clinician JUdgment Versus Risk Score to Predict Stroke outComes: The JURASSIC Clinical Trial
NCT01657279 ·Status: COMPLETED ·Phase: NA
-
Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)
NCT00243880 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
NCT01518231 ·Status: UNKNOWN ·Phase: PHASE1
-
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
NCT04253275 ·Status: COMPLETED ·Phase: NA
-
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
NCT02549846 ·Status: COMPLETED ·Phase: PHASE4
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)
NCT00401310 ·Status: TERMINATED ·Phase: PHASE2
-
Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
NCT03519737 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
NCT05764122 ·Status: WITHDRAWN ·Phase: PHASE2
-
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
NCT01455935 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
NCT01282242 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial
NCT01020851 ·Status: COMPLETED ·Phase: NA
-
Trial of a Secondary Stroke Prevention Program
NCT01071408 ·Status: COMPLETED ·Phase: NA
-
The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation
NCT06864052 ·Status: NOT_YET_RECRUITING ·Phase: NA